With 72 sites nationwide, the American Red Cross is the largest single provider of autologous Mononuclear Cell (MNC) Collections for cell therapy and a proven partner in providing patient access to our client’s drug or developing cell therapy products requiring a MNC collection.
Economies of scale and cross-utilization of technology allow us to offer you cost-effective autologous collection services and provide high-quality source material for commercial production as well for clinical trials.
A Nationwide Network of 72 Collection Sites
Your nationwide partner for all your autologous MNC collection needs
When partnering with the Red Cross, you gain access to a network of resources with years of experience to help you every step along the way.
50,000+ Collection Procedures
Our geographical breadth of collection sites with significant expansion potential, enables us to reduce the time between donor collection and product delivery. Product can be shipped fresh or frozen and packaged according to client specifications
100% of all FDA Approved T-Cell Therapies Supported
We support 100% of all FDA approved T-cell therapies – as well as perform collections in support of clinical trials. Collection services are available at American Red Cross sites, hosting institutions, or at Principal Investigator’s facility
10+ Years' Experience
With significant expertise in providing high-quality source material for commercial production, we offer economies of scale and cross-utilization of technology in each region, allowing us to offer you cost-effective autologous collection services
A Dedicated Client Team For Consistent Service and Reliable Results
A dedicated Client Relationship Management team at the American Red Cross provides a single point of contact for clients and ensures standardization in services across our nationwide sites. Our ability to perform autologous MNC collections across the country allows our clients to offer subjects enrolled in their study's geographical convenience. Also, our expertise in providing hospital-based therapeutic apheresis and stem cell collections services allows us to provide in-hospital collections when needed.
Our skilled nursing staff is experienced in apheresis collections via peripheral or Central Venous Catheter (CVC) access and in performing CVC dressing changes. Utilization of staff across geographies ensures appropriate nationwide coverage, regardless of uneven demand.
Our national quality standards help ensure consistent collections according to American Red Cross procedures and client-specific manuals. All American Red Cross collection sites operate under one Quality Management System (QMS) and one set of national procedures, resulting in a streamlined audit process for our clients. These allow for one single systemwide audit, with local audits focused on the review of individual-site items, such as local staff training and equipment records.
American Red Cross has experience in implementing client-specific product sampling and testing, patient testing — including infectious disease and complete blood count — as well as packaging and shipping requirements in accordance with your manuals.
Flexible Contracting Arrangements
The American Red Cross offers direct contracting with trial sponsors to enable rapid onboarding of new principal investigators and hosting institutions while providing a direct billing structure that improves cost management. We can also contract with the hosting institution, depending upon client preference.
Cell Processing, Cryopreservation and Storage Services
Our full-service cell therapy labs across the country perform processing, freezing, and storage of mononuclear cell products either according to your protocol or Red Cross protocols. If needed, the products can be frozen before shipment or be stored at an American Red Cross facility. Product testing can be provided, including sterility, viability, endotoxin, and immunophenotyping, as well as other requests. We offer same-day processing and cryo-preservation post-collection in select geographies.
Complimentary Client Services
CBC sample draw and testing if multiple procedures will be performed.
Per procedure review of CBC results and relevant medical history.
Physician and patient education on leukapheresis procedures.
Post-procedure feedback to prescribing physician or principal investigator.
Central venous catheter care, including dressing changes.
Provision and utilization of heparin to lock catheter.
Since 2010 the American Red Cross has played an essential role in the delivery of PROVENGE® (sipuleucel-T) – an autologous cellular immunotherapy for the treatment of men with advanced prostate cancer.
Their national network of blood collection centers facilitate the successful commercial delivery of PROVENGE and ensure convenient access to services for PROVENGE patients nationwide. We are grateful to the American Red Cross for their support and strong partnership.
Equally innovative and reliable, we value their expertise, attention to detail and shared commitment to our patients.
- Serena Stewart Vice President, Patient Operations Dendreon Pharmaceuticals
American Red Cross Cell and Gene Therapy Solutions Fireside Chat with Dendreon
Advanced Therapies Connect 2021, Jan 26-27, 2021
Learn how the we were able to keep patients safe, keep our collection centers open and help Dendreon continue to provide life-saving therapy during the COVID-19 pandemic.